Abstract. Agrin is a basal lamina protein that induces aggregation of acetylcholine receptors (AChRs) and other molecules at the developing neuromuscular junction. Alternative splicing of chick agrin mRNA at two sites, A and B, gives rise to eight possible isoforms of which five are expressed in vivo. Motor neurons express high levels of isoforms with inserts at sites A and B, muscle cells synthesize isoforms that lack amino acids at the B-site. To obtain further insights into the mechanism of agrin-induced AChR aggregation, we have determined the ECs0 (effective concentration to induce half-maximal AChR clustering) of each agrin isoform and of truncation mutants. On chick myotubes, ECs0 of the COOH-terminal, 95-kD fragment of agrinA4a8 was ,'~35 pM, of agrinA4aZ9 ~110 pM and of agrinA4a, --5 nM. While some AChR clusters were observed with 64 nM of agrinA4aO, no activity was detected for agrinAoa0. Recombinant fulllength chick agrin and a 100-kD fragment of ray agrin showed similar ECso values. A 45-kD, COOH-terminal fragment of agrinA4u retained high activity (ECso ----130 pM) and a 21-kD fragment was still active, but required higher concentrations (ECs0 ---13 nM). Unlike the 45-kD fragment, the 21-kD fragment neither bound to heparin nor did heparin inhibit its capability to induce AChR aggregation. These data show quantitatively that agrinA4nS and agrinA4mg, expressed in motor neurons, are most active, while no activity is detected in agrinAoBo, the dominant isoform synthesized by muscle cells. Furthermore, our results show that a fragment comprising site Bs and the most COOHterminal G-like domain is sufficient for this activity, and that agrin domains required for binding to heparin and those for AChR aggregation are distinct from each other.
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T HE formation of chemical synapses in the nervous system requires exchange of local signals between preand postsynaptic cells. At the neuromuscular junction (NMJ) ~, muscle cells aggregate several proteins, such as acetylcholine receptors (AChRs), acetylcholinesterase, and heparan sulfate proteoglycans at the site of contact between nerve and muscle cell. This process is, at least in part, initiated by the release of molecules from the motor axon. Several lines of evidence suggest that agrin, a component of synaptic basal lamina, is such a molecule. On cultured myotubes, agrin induces aggregation of several molecules that are concentrated at the NMJ including AChRs (Nitkin et al., 1987; Wallace, 1989) . Motor neurons synthesize agrin, transport it to the nerve terminal from where it is released to induce AChR aggregation McMahan, 1988, 1990; Reist et al., 1992; Cohen and Godfrey, 1992) .
1. Abbreviations used in this paper: AChR, acetylcholine receptor; NMJ, neuromuscular junction. cDNAs encoding agrin have been cloned in rat, chick, and the marine ray Tsim et al., 1992; Smith et al., 1992) . The deduced protein from full-length cDNAs of rat and chick has a calculated Mr of more than 200 kD. It contains several domains that are homologous to motifs found in other proteins of the extracellular matrix. Within the COOH-terminal half of agrin, two sites are altered as a result of alternative mRNA splicing Rupp et al., 1992) . In chick, the sites are referred to as site A and site B ; the same sites in rat are called y and z . Site A encodes 4 amino acids and site B codes for either 8, 11, or 19 (8 + 11) amino acids. By PCR techniques, it has been shown in chick,and rat that isoforms containing inserts at the B-site always carry inserts at the A-site Hoch et al., 1993) . Thus, alternative mRNA splicing at the two sites is coordinated and thereby the number of agrin transcripts expressed in vivo, that differ at sites A and B, is restricted to five. In this report we refer to the isoforms encoded by these transcripts as agrin~oao, agrinA4B0, agrinA4ss, agrin^4B,, and agrinA4B,9. Alternatively spliced mRNAs are expressed tissue specifically and depend upon the developmental stage. Single cholinergic neurons of chick ciliary ganglia contain mixtures of mRNAs encoding Bo, Bs, B., and B19 inserts.
The relative amount of each transcript varies during development, nevertheless the most abundant mRNA at embryonic days 6-20 encodes agrin^4B19 (Smith and O'Dowd, 1994) . At embryonic days 5 and 6, chick motor neurons also express high levels of agrin^4m9 (Ruegg, M. A., M. J. Werle, S. E. Horton, L. S. Honig, and U. J. McMahan, manuscript in preparation). Transcript specific in situ hybridizations indicated that, later in development, agrin^4m9 mRNA is downregulated and mRNA for agrin^4~ becomes most abundant in motor columns (Honig, L. S., D. Stone, K. Nikolics, and U. J. McMahan. 1993 . Soc. Neurosci. Abstr. 1272 . Thus, cholinergic neurons express a mixture of agrin isoforms and depending on the developmental stage, agrin^4,s or agrin^,B19 is most abundant. Nonneuronal and muscle ceils, on the other hand, express only mRNA encoding agrin^4B0 and agrinmB0 Hoch et al., 1993; Ma et al., 1994; Smith and O'Dowd, 1994) .
The COOH-terminal half of agrin^4BH is sufficient to induce AChR clustering on cultured primary myotubes and this activity is indistinguishable from that of purified Torpedo agrin . When tested in a qualitative way, this activity was dependent on the presence of amino acids at both sites A and B . Similarly, AChRaggregating activity of rat agrin differs between isoforrns, although the extent of the changes in activity depended on the experimental conditions, such as the origin of muscle cells and the size of rat agrin (Ferns et al., 1992 .
Several lines of evidence suggest that agrin binds to receptors on the muscle cell surface and that aggregation of AChRs is mediated by an intracellular cascade. Before aggregation the/3 subunit of the AChR becomes tyrosine phosphorylated (Wallace et al., 1991) . Staurosporine, a nonselective antagonist of protein kinases, blocks both phosphorylation of the/~ subunit and AChR aggregation (Wallace, 1994) , supporting the view that phosphorylation and aggregation of AChRs are causally linked.
Evidence for an agrin-binding site on muscle cells has been published by Nastuk et al. (1991) . This binding protein has been characterized biochemically from postsynaptic membranes of the electric organ of Torpedo californica (Ma et al., 1993; Bowe et al., 1994) . Peptides derived from this binding protein are highly homologous to ct-dystroglycan (Bowe et al., 1994) . Indeed, recent experiments have shown that an ,,d00-kD fragment of rat agrin binds specifically to this peripheral membrane protein on muscle cells. Its binding is Ca2+-dependent and is inhibited by low concentrations of heparin Gee et al., 1994; Sugiyama et al., 1994) . a-Dystroglycan is a component of the dystrophin-glycoprotein complex, which forms, via dystrophin, a network with the cytoskeleton. Earlier studies showing that laminin binds to ot-dystroglycan (IbraghimovBeskrovnaya et al., 1992) suggested that the dystrophinglycoprotein complex links basal lamina and cytoskeleton of muscle cells to confer physical stability of the sarcolemma and to guarantee maintenance of calcium homeostasis during contractions (for a recent review see Matsumura and Campbell, 1994) . The finding that agrin binds to ot-dystroglycan has suggested that this protein complex may also be important for the formation of the NMJ. A question that remains is whether binding of o~-dystroglycan induces the intracellular signaling cascade that triggers aggregation of AChRs on cultured muscle cells (see also Sealock and Froehner, 1994; Sugiyama et al., 1994) .
The aim of our work was (a) to determine quantitatively the activities of agrin isoforms synthesized by neurons and by nonneuronal ceils and (b) to establish how individual domains of agrin contribute to its AChR-aggregating activity. Our results show that agrin isoforms with the 8-amino acid insert at site B are most active, while absence of amino acids at this site lowers the activity by more than three orders of magnitude. Furthermore, we show that a COOH-terminal, 21-kD fragment of agrin is sufficient for this activity. AChR aggregation induced by this fragment is not inhibited by heparin. Hence, the heparin-binding site of agrin is not required to activate the signal-transducing receptor.
Materials and Methods

Polymerase Chain Reaction and Oligonucleotides
Conditions for PCR were as follows: 20 mM Tris-HC1 (pH 8.4), 50 mM KCI, 2.5 mM MgCI2, 0.2 mM of each dNTP, 50 pmol of each primer and 2.5 U ofTaq polymerase (GIBCO BRL, Galthersburg, MD). Reaction volume was usually I00 pl. Numbering of oligonucleotides is according to the sequences published by Tsim et al. (1992) and Smith et al. (1992) . All PCR products used to generate expression constructs were cloned into PCR 1000 or PCR II cloning vectors (Invitrogen, San Diego, CA) and sequenced to ensure that no mutations were introduced by DNA amplification. To distinguish expression constructs and recombinant protein, cDNA constructs are named with the prefix p followed by the name of the recombinant protein they encode.
Identification of SpUce Variants in Chick and the Marine Ray
Reverse transcriptase-polymerase chain reaction was conducted as described in Ruegg et al. (1992) . For chick, poly (A) + RNA from embryonic day 10 dorsal root ganglia served as a template, while for the marine ray, mRNA isolated from electric lobe of adult Discopyge ommata was used. Oligonucleotides used for chick were s5381 (TTT COT GGT AGG ACG TAC AT) and as5491 (CTT CTG TTT TCJA TGC ~ GC); for the marine ray s3451 (GC~ CGC ACA TIC ATT GAG TAT CAC) and as3511 (TTC AAA ATA ATT AAC TTG T). PCR products were cloned into PCR 1000 (Invitrogen) and sequenced using Sequenase 2.0 (USB, Cleveland, OH). The chick sequence of Bi9 was identical to that submitted to the GenBank by Thomas et al. (1993) . The protein sequence for Bs of Discopyge ommata has been published by McMahan et al. (1992) . Nucleotide sequence data are available from EMBL/GenBank/DDBJ under accession number U16146.
Expression Constructs
Constructs Encoding the 95-kD Fragment of Chick Agrin. All agrin constructs used in this work contain an artificial ER signal sequence derived from hemngglutinin of the avian influenza virus described by Tsim et al. (1992) . This signal sequence was inserted into the expression vector pcDNAI (Invitrogen).
The constructs encoding the COOH-terminal half of chick agrin (c95) are based on ARP-2coN^ . Pc95^4Bn was generated as previously reported . The insert for pc95^4at9 was obtained by fusion of overlapping DNA fragments derived from CBA-I and the cloned PCR product encoding the BI9 isoform (see above). The fused DNA fragment, spanning nucleotides 5023-5827 in chick agrin, was cloned into PCR 1000 (Invitrogen) and a eDNA fragment with the BI9 site was excised by XhoI and ApaI restriction endonucleases and was inserted into pc95^4an as previously described . PC95A4a8 was obtained by fusing overlapping PCR products. To achieve this, a Xhol-ApaI restriction fragment of pc95Aoa0 was inserted into Bluescript vector KS + (Stratagene Corp., La JoHa, CA). PCR was performed using T3 as a sense primer (ATT AAC CCT CAC TAA AGG GA) and the antisense primer as5408 B8 (GGG ATC ~ TTG CTC AGG TGG CTC TTT GTC ACG GCA TTG T). The second reaction was made using T7 primer (TAP, TAC GAC TCA CTA TAG GG) and the sense oligonucleotide B8 s5457 (ACC TGA GCA ATG AGA TCC CTG CCG AGA AGG CTT IV_JC AAT CC). After isolation from agarose gel, the two fragments were fused by PCR amplification in the presence of T3 and T7 primer. The PCR product was purified, cut with XhoI and Apal restriction endonncleases, and exchanged with the corresponding fragment in pC95A4aU. PC95A4aO was made by replacing a ClaI-XbaI fragment of pc95A4m9 with the corresponding fragment obtained from ClaI-XbaI digestion of ARP-lct~NA .
Construction of Full-Length Chick Agrin. eDNA clones PE-3 and PE-1 that encode the 5' end of chick agrin were joined by PCR: Amplification was conducted on PE-3 with s6 (CCT TAA TCT O'I'G ACA AC) and as934 (CCA CCG CTT CAG GCA GAC AGC) as primers, and on PE-1 with s903 (GGA CAA ATG CAA GGA "I13) and as1662 (GGC AGG AGG CTG CTC GG) as primers. Both PCR products were gel purified and fused by DNA amplification using primers s6 and as1662. The resulting PCR products were inserted into PCR 1000 vector (Invitrogen) and several clones were sequenced. One clone with no mutations was joined with PE-1 by restriction digestion with ApaI and ligation with the insert of PE-1, cut with ApaI. The resulting insert in PCR 1000 comprised agrin sequences from nucleotide 6-3690. This clone was subsequently digested with BamHl and ligated to CBA-1 that had been cut with the same restriction endonuclease. Clones were screened for the correct orientation and the insert comprising full-length chick agrin was moved into the expression vector pcDNAI by excision with EcoRl.
To facilitate work with this expression construct the BamHi restriction site, located in the polylinker at the 5' end of full-length agrin, and the EcoRI-site at the 3' end were both destroyed by restriction digest with the corresponding endonuclease, followed by filling recessed ends by treatment with Klenow polymerase and religation. This led to a full-length cDNA construct (pCA) with a unique EcoRI site at its 5' end and a unique XbaI site at its 3' end. Exchange of the endogenous, putative signal sequence with the hemagglutinin signal sequence was achieved as follows: PCR was conducted onpCA and primers EcoRI s193 (AGC TTG AAT TCG AAG CCC AAT AGC TAT TTT ACC CAG) and as1036 (TTT CTG CCG CTC ACA GTC ATT). The resulting PCR product was gel purified, digested with EcoRI and BssHII, and inserted into the EcoRI/BssHII cut pCA. Fusion to the artificial signal sequence was completed by cutting the PCR-modified, full-length eDNA with EcoRI and Xbal restriction enzymes and iigating the insert into pcDNAI containing the signal sequence giving rise to pcFullA4aU. Constructs with different B-sites were generated by exchanging ClaI-SmaI restriction fragments isolated from the corresponding pc95-constructs. PcFullA0a0 was obtained by replacing the BamHI-XbaI fragment in pcFullA4m i with the corresponding fragment of ARP-2cDNA .
Constructs Encoding 43 kD and 21 kD Fragments. /~,45 constructs
were generated by PCR using pC95A4BS as template together with the oligonucleotides EcoRI s4648 (AGC TTG AAT TCG GAG CAG GAC CAC ACC A) and an antisense primer corresponding to the nncleotide sequence of Ba, as-B8 (GCA GGG ATC TCA TTG CTC AGG TGG), The PCR product was gel purified, digested with EcoRI and Clal, and inserted into pcFulIA4BS or pcFuilA0a0, respectively. Pc21Bs and pc21a0 were generated by PCR using pCaSA4BS and pc45A0a0 as templates together with EcoR/ s5351 (AGC TTG AAT TCA GCT GGA GAT GCA GAG G) and as6146 XbaI (CCG GGT CTA GAC TTG GTT CAA GGT TT). PCR products were purified from agarose gels and digested with EcoRI and XbaI. After isolation from agarose gels, fragments were ligated into EcoRI-Xbal cut pcDNAI expression vector containing the signal sequence. The complete coding region was sequenced in order to verify the PCR fragment.
Constructs Encoding 100 kD Fragment of the Marine Ray. To gener-
ate an expression construct, the partial cDNA clone OL4 encoding agrinA4a0 of Discopyge ommata (Smith et al., 1992) served as template.
cDNA was digested with NarI and recessed ends were filled with Klenow polymerase. After digestion with XbaI restriction endonuclease and purification on agarose gel, the fragment was inserted into pcDNAI containing the signal sequence that had been cut with EcoRI, filled with Klenow polymerase and redigested with XbaI. This procedure yielded prl00a4aO encoding recombinant agrinA4aO that is 35 amino acids longer than the 95-kD fragment isolated from basal lamina extracts of the electric organ of Torpedo californica (for NH2 terminus of the 95-kD fragment, see Smith et al., 1992) . To generate prl00A4Bs, prl00A,m0 was digested with HindlII restriction endonnclease and inserted into HindlII-cut PeDNAI. A first PCR was performed on this construct with T7 and as3479 B8 (TGG GAT CTC ATT "IVJC AAG ATG GCT CCT TGT CAC TGT GTT GT) as primers. A second PCR on the same template used SP6 (CAT TTA GGT GAC ACT ATA G) and B8 s3498 (ATC TTG CAA ATG AGA TCC CAG ATG AGA AAG CTG TAC AAG TT) as primers. After purification, the two products were fused in a third amplification using primers 1"7 and SP6. The PCR product was cloned into PCR II vector (Invitrogen), digested with both Eco47III and SphI, and the resulting DNA fragment was exchanged with the corresponding fragment ofprl00A4a0.
Tissue Cultures
Chick Myotube Cultures. Myotube cultures were prepared from hind limb muscles of ll-12-d White Leghorn chick embryos by the method of Fischbach (1972) . Modifications of these procedures were as follows: freshly dissociated myoblasts were plated in a density of ",,1.5 × 105 cells onto 35-mm plastic tissue culture dishes previously coated with 0.3 nag gelatin (Sigma Chem. Co., St. Louis, MO). Growth medium consisted of MEM (G1BCO BRL) supplemented with 10% horse serum (GIBCO BRL), 4% chick embryo extract (prepared from I 1-d-old chick embryos with an equal volume of Puck's saline G [Puck et al., 1958] ), 100 U/ml penicillin (GIBCO BRL) and 100/~g/ml streptomycin (GIBCO BRL). After 2.5 d, growth medium was replaced by differentiation medium consisting of growth medium with only 2% chick embryo extract and 0.5 x 10 -5 M cytosine arabinoside (Sigma Chem. Co.). Cultures were used 3.5-4.5 d after plating.
C2C12 Cell Line. C2C12 cells were proliferated in DME containing 10% horse serum (GIBCO BRL), 10% newborn caif serum, 100 U/ml penicillin, and 100/~g/ml streptomycin. Approximately 0.5 x 105 cells were plated on gelatin-coated 35-mm tissue culture dishes and after one day, medium was replaced with DME containing 2% FCS (GIBCO BRL), 100 U/mi penicillin, and 100 ~g/ml streptomycin. After 4-6 d, cells had fused and AChR aggregation assays were performed.
Transfection and Culturing of COS-7 and 293
Cells. COS-7 (Gluzmann, 1981) and 293 (Graham et al., 1977) cells were cultured in DME (GIBCO BRL) supplemented with 10% newborn calf serum, 10 mM sodium pyruvate, 100 U/ml penicillin, and 100 mg/ml streptomycin (all from GIBCO BRL). COS-'/cells were transiently transfected with the DEAEdextran-based method described by Cullen (1987) . 293 cells were transfected by the method described by Gorman et al. (1990) . Supernatants were usually collected 3 d after transfection.
To establish stably transfected cell lines, 293 cells that had been plated onto a 100-mm tissue culture dish at 70% confluence were transfected with agrin constructs together with 1/10 of a helper plasmid (pRSV-Tneo; Gotman et al. [1990] ) that carried a neomycin resistance gene. One day after transfection, cells were plated onto two or three 100-mm culture dishes and 600/zg/ml (3418 (GIBCO BRL) was added to the medium. After 2-3 wk, individual colonies were picked and stained intracellularly with mAb 5B1 or the polyclonal anti-agrin antiserum. Colonies expressing high levels of recombinant agrin were cloned by limited dilution into 96-well plates. Positive clones were selected and grown in medium without G418.
Quantification of AChR Aggregation
Chick muscle cells or C2C12 myotubes were incubated with agrin for 16 h at 37°C. In experiments where the effect of heparin (grade I, Sigma Chem. Co.) on AChR aggregation was measured, muscle cells were exposed to agrin for only 6 h under serum-free conditions as described (Wallace, 1988) . Cells were then rinsed with DME-F12 (Sigma), 1 mg/ml BSA (Fluka, Buchs, Switzerland), and incubated in the same medium containing 4 × 10 -s M rhodamine-t~-bungamtoxin (Molecular Probes, Eugene, OR) for 45-60 min at 37°C. Cultures were washed twice with DME-F12, 1 mg/ml BSA followed by one rinse with MEM. They were fixed with 95 % ethanol for 5 min at -20"C and mounted on glass coverslips with 90% glycerol, 10% PBS. Cultures were examined at a magnification of 400x on a microscope equipped with epifluorescence (AH-2; Olympus Optical Co., Tokyo, Japan). To determine the extent of AChR clustering, segments of healthy myotubes were chosen under phase optics, and both phase and rhodamine optics were imaged with a SIT-camera (model 66; Dage-MTI, Michigan City, IN) that was connected to an imaging system (Image-l/AT; Universal Imaging, West Chester, PA). The threshold of the digitized images was set by eye such that AChR aggregates were clearly distinct from background labeling of myotubes. The threshold was kept constant throughout the analysis of one series of experiments. Myotubes were outlined manually and AChR aggregates (i.e., objects above threshold) were counted within the outlined area. Only AChR aggregates with a longer axis of at least 4 ~m were included in the counting. For chick myotubes, data were ex-pressed as number of AChR aggregates in a normalized area (100/zm x 100 t~m) of a myotube segment. Because of the shape of AChR aggregates on C2C12 cells, the ratio of areas occupied by AChR aggregates to total area of the myotube segment proved to be more accurate as a measure of agrin's activity. In each 35-mm culture dish, 10 individual myotube segments were counted. Pictures taken in phase optics were used to exclude non-specifically labeled cell debris. Antibodies mAb 5B1 (Reist et al., 1987) was a kind gift of Dr. U. J. McMahan (Department of Neurobiology, Stanford University School of Medicine, CA). To purify IgGs, hybridomas were grown in DME containing 10% IgG-depleted FCS (GIBCO BRL). Conditioned medium was buffered with 20 mM Hepes (pH 7.2) and applied to protein G-Superose (Pharmacia, Uppsala, Sweden). After washing with 20 mM sodium phosphate, pH 7.0, IgGs were eluted with 100 mM glycine-buffer (pH 2.7) and immediately neutralized by adding 1/10 vol of 1 M Tris-HCl (pH 7.0). Polyclonal antisera were raised in two rabbits by injecting immunoaflinity-purified C95A4aU. For the first injection '~,60 #g of protein in complete Fround's adjuvant were used. For booster injections in 4-8-wk intervals, the same amount of C95A4m~ was dissolved in incomplete Freund's adjuvant. Titer of anti-c95A4ml IgG in the sera was determined by immunoprecipitation of agrin-containing medium of stably transfected 293 cells and by staining cryostat-sections of embryonic day 18 chick pectoral muscle.
Purification of Recombinant Agrin. mAbs 5B1 were covalently coupled to Afli-10 beads (BioRad Labs, Hercules, CA) according to the manufacturer's instruction. Conditioned media of transiently or stably transfected cells was loaded onto the column with a flow rate of '~20 ml/h. The column was washed sequentially with 20 vol each of 50 mM Tris buffer, pH 7.5, containing 150 mM NaC1, 5% glycerol, 0.5% Triton X-100; Tris buffer containing 1 M NaCl, 5% glycerol and 0.5% Triton X-100 and Tris buffer containing 150 mM NaCI and 5% glycerol. Columns were eluted with 10 vol of 50 mM triethylamine, pH 11.5, containing 150 mM NaCI and 5% glycerol. Fractions (1.5 ml) were collected and immediately buffered with 180 #1 of 1 M Tris-HCl, pH 7. Aliquots of each fraction were analyzed on 7.5% SDS-PAGE and proteins were visualized by silver staining (Morrisey, 1981) . Fractions with high concentrations of agrin were pooled and dialyzed three times against 1.5 liter of PBS. Centricon-30 concentrators (Amicon Corp., Danvers, MA) were used to concentrate agrin. Agrin concentration was determined according to Lowry et al. (1951) using the DC Protein assay kit (BioRad Labs) and BSA as a standard. As an independent measure, the relative intensity of agrin on silver-stained gels was estimated by dilution series of known amounts of bovine serum albumin. Highly pure fractions with known concentrations of agrin were used as internal standards in the ELISA.
Agrin Binding to Heparin Columns. 2 ml of heparin (type II)-agarose beads (Sigma Chem. Co.) were used as heparin affinity columns. 2.5 ml of 35S-labeled conditioned media from COS cells transfected with pC45A41~S or pC21BS were loaded onto separate heparin columns. Bound proteins were eluted with 2.5 ml of 50 mM Tris-HCl, pH 7.5, containing 500 mM NaCI, and 5% glycerol. Aliquots of the flow through and the eluate were immunoprecipitated as described below.
Quantification of Agrin
ELISA. ELISA was essentially done as described by Ruegg et al. (1989) with the following modifications: mAb 5B1 (10/~g/ml) was immobilized on microtiter plates followed by incubation of c95 proteins at a concentration between 0.5 and 10 ng/ml. As a secondary antibody, purified rabbit anti-C95A4B, IgG at a concentration of 5.6 ~g/ml was used. To eliminate crossreactivity of IgG with 5B1, antiserum was always preadsorbed with 5B1 beads. The third antibody, a peroxidase-conjngated goat anti-rabbit IgG (BioRad Labs) was used in a 1:2,000 dilution. The detection limit of this procedure was ,050 pg of agrin. As an internal standard, purified recombinant c95 protein with known concentration (see above) was used.
Metabolic Labeling, Imraunoprecipitation, and Quantification. Independent of ELISA, concentrations of recombinant agrin in conditioned medium oftransfected cells was determined as follows: six hours after transfection, medium was changed to 25% DME, 65% MEM without methionine, 10% IgG-depleted FCS (all from GIBCO BRL) and 50 btCi/ml [35S]methionine (Du Pont, Bad Homburg, Germany). Cells were grown in this medium for 2.5 d. Except for c45 and c21-contalning medium, aliquots were removed for independent measure of the agrin concentration by ELISA. Aliquots used for immunoprecipitations were 300 /~1 (c95-fragments) and 30/zl (c45-and c21 proteins). Volumes were adjusted to 1 ml with a 50-mM Tris-HCl buffer, pH 7.5, containing 5% glycerol and 150 mM NaCI and 10 #1 of rabbit anti-grin antisera was added. After incubation for 3 h at 4°C, 60/~1 of a 30% suspension of protein A-Sepharose (Pharmacia) in 0.14 M sodium phosphate, pH 8.3, was added and incubation was continued for an additional 90 min. Supernatant was removed and subjected to a second immunoprecipitation to guarantee that agrin had been depleted in the first round by at least 90%. The beads were then washed sequentially as described for immunoatlinity columns, except that NaCI was raised only to 625 mM. Bound antigen-antibody complexes were released by boiling for 5 min in 60/zl of SDS-PAGE sample buffer (Laemmli, 1970) . Samples were separated by SDS-PAGE on a 3-12% gradient gel. Gels were dried and the amount of [35S] incorporated into recombinant agrin was quantified by volume integration with a Phosphorlmager (Molecular Dynamics, Sunnyvale, CA). To calculate the molar amount of different agrin fragments, the radioactivity incorporated was corrected with the number of methionines present in different agrin fragments. Concentrations of c45 and c21 in conditioned medium was determined by comparison of incorporated radioactivity with that of immunoprecipitated C95A4BS, whose concentration had also been determined by ELISA.
Results
cDNA Constructs, Heterologous Expression, and AChR-clustering Activity of Agrin Isoforms
Most studies of the molecular mechanisms of agrin-induced AChR aggregation and of the binding properties of agrin have used purified protein from the electric organ of Torpedo californica (e.g., Wallace, 1988 Wallace, , 1989 Wallace et al., 1991; Ma et al., 1993) . The main protein containing AChRaggregating activity in these fractions has an apparent Mr of 95 kD (Nitkin et al., 1987) . To compare activities of agrin isoforms with previous results, we used ARP-2cDNA ) as a template. The protein encoded by ARP2eDNA is expected to have the same size as the 95-kD protein from Torpedo californica. We also tested whether regions in the NH2-terminal half of full-length agrin would affect activity by generating cDNA constructs that encode the complete amino acid sequence of the mature chick agrin protein . Finally, we generated constructs encoding recombinant agrinA4B0 and agrinA4Bs of the electric ray, Discopyge ommata, to compare activity of agrin isoforms from different species. The structure of recombinant agrin fragments and their nomenclature is shown in Fig. 1 .
Recombinant protein was obtained by transfecting cDNA constructs into COS-7 (Gluzman, 1981) or 293 cells (Graham et al., 1977) . Recombinant agrin in the conditioned medium was identified by immunoprecipitation with mAb 5B1 (Reist et al., 1987) or a polyclonal antiserum raised against recombinant c95A4mt. Fig. 2 shows a fluorogram of the recombinant proteins that had been resolved by SDS-PAGE. The apparent Mr of '~95 kD of recombinant chick c95 proteins fits well with the predictions from protein purified from Torpedo californica. Recombinant agrin encoded by the ray cDNA, rl00A,as, has an apparent Mr of ~100 kD, which is expected because it is 44 amino acids longer than the corresponding c95-isoform in chick (Fig. 2) . Recombinant full-length chick agrin, whose putative signal sequence had been replaced by the signal sequence of hemagglutinin of the influenza virus, is secreted efficiently by COS and 293 cells. It migrates on SDS-PAGE as a broad smear with an apparent Mr of 400-600 kD (Fig. 2) . Deglycosylation experiments with heparitinase, chondroitinase ABC, and keratanase indicate that recombinant chick agrin is a heparan sulfate proteoglycan (Denzer, A. J., M. Gesemann, and M. A. Ruegg, unpublished observation). Consistent with this observation, several potential glycosaminoglycan side chain attachment sites (Bourdon et al., 1987) are found in agrin and the positions of some of these sites are conserved in chick, rat, and electric ray (see Fig.  1 ). The possibility that agrin exists in vivo as heparan sulfate proteoglycan is substantiated by the findings of Hagen et al. (1993) , who characterized heparan sulfate proteoglycans from bovine renal basement membranes. Two tryptic peptides from a purified proteoglycan are highly homologous to rat and chick agrin, suggesting that, at least in kidney, agrin may be a heparan sulfate proteoglycan.
To measure the concentration of recombinant agrin in the conditioned medium of transfected cells, we established an ELISA using mAb 5B1 and polyclonal anti-c95^4en antisera. The accuracy of this method was tested by comparing the results from the ELISA with those obtained by immunoprecipitation of 35S-agrin. As shown in Table I , the two methods yielded the same results for chick agrin isoforms irrespective of their size. The concentration of rl00^4Bs determined by ELISA was only 60 % of that obtained by immunoprecipitation, which is most likely due to the lower avidity of the anti-c95A4B, antiserum to ray agrin. Thus, the ELISA is a valuable tool for determining the concentration of recombinant agrin in conditioned medium of transfected cells. Consequently, this method was used in the subsequent experiments.
First, we tested the effect of different agrin isoforms on the maximal number, size, and shape of AChR aggregates by incubating cultured chick myotubes for 16 h with excess of recombinant protein. AChRs were visualized using rhodamine-labeled t~-bungarotoxin. As a control, conditioned medium of mock-transfected COS cells was added (Fig. 3 a) . No AChR clustering was detected with 64 nM C95AOB0 (Fig.  3 b) , while some activity was observed with this high concentration of C95A4B0 (Fig. 3 C) . On the other hand, AChR aggregates were induced by C95A4Bjl (Fig. 3 d) , C95A4m9 Relative amount of agrin in conditioned medium of COS cells that expressed the indicated fragments, was determined by ELISA and immunoprecipitation with anti-agrin antiserum. Incorporated radioactivity was determined by a Phosphorlmager as described in Materials and Methods. The number of methionineresidues in the recombinant protein were used to calculate the amount for each fragment. Values are means + SEM of three independent experiments. Amount determined for c95^4B, was set to 100%. Both methods give the same results for all chick fragments, while for ray agrin, ELISA detects only '~60% of the concentration determined by immunoprecipitation. *, No significant difference between both methods (p > 0.1). *% Significant difference (p < 0.01).
( Fig. 3 e) , and C95A4Bg (Fig. 3 f ) . Recombinant chick cFuI1A4B8 and ray rl00A,Bg were also active (Fig. 3, g and h) . The maximal number, sizes, and shapes of AChR aggregates induced by the active agrin isoforms were the same (Fig. 3, formed AChR aggregates, which are smaller in size than those induced by agrin ( Fig. 3 ; Godfrey et al., 1984) were accounted for by excluding clusters in which the longer axis was less than 4 #m. As shown in Fig. 4 , the most active isoform on chick myotubes was C95A,BS. Its ECs0 (effective concentration needed to induce a half-maximal response) Because agrin-induced AChR aggregates are less frequent, but larger than on chick myotubes, agrin's activity is expressed as percentage area of AChR clusters. C2C12 myotubes respond to agrin isoforms similarly as primary chick myotubes. At was 35 + 3 pM (mean + SEM; N = 4). The second most active isoform was C95A4m9 with an ECso of 108 + 12 pM (mean -I-SEM; N = 3), followed by C95^4BH with 5 -I-1 nM (mean -I-SEM; N = 3). No detectable activity was observed with C95A0~0 even at concentrations of 64 nM. For c95^4Bo, we observed low levels of activity, but only at very high concentrations (64 nM). Some AChR-aggregating activity of affinity-purified agrin-like proteins from nonneuronal tissue was observed by Godfrey (1991) , which may be based on the presence of this weakly active agrinA4Bo.
d-h).
To elucidate whether sequences in the NH2-terminal half of chick agrin may contribute to its AChR-aggregating activity, we compared the dose response curves of the most active COOH-terminal half, C95A4SS, with that of cFullA4~. As shown in Fig. 5 a, the two curves overlap almost perfectly. Like c95Ao~0, cFuI1AoB0 did not induce AChR aggregation at concentrations of up to 4 nM (4 nM of cFull~oBo: 2.31 + 0.34 AChR clusters/10,000/~m2; blank: 2.43 + 0.27 AChR clusters/10,000/xm2). Thus, the presence of the NH2-terminal half of chick agrin has no effect on AChR aggregation on chick myotubes.
Since most previous experiments on AChR aggregation used agrin purified from the electric ray, we also compared the activity of recombinant ray and chick agrin. We generated cDNA constructs encoding the COOH-terminal half of ray agrinA4BS and agrin^4Bo using cDNA clone OL4 (Smith et al., 1992) . When tested on chick myotubes, the dose dependence of AChR clustering induced by rl00A4B8 waS similar to that of C95A4BS (Fig. 5 b) . As expected from the results using recombinant chick agrin, no activity was detected with 4 nM of rl00A4~0 (rl00A4S0:1.93 + 0.24 AChR clusters/ 10,000 /~m2; blank: 1.79 + 0.28 AChR clusters/10,000 /zm2). If we account for the systematic error in determining the concentration of ray agrin by the ELISA (Table I) , rl00A4B8 is '~1.5 times less active than shown in Fig. 5 b. Nevertheless, these experiments show that homologous isoforms of the marine ray and chick have similar activities.
Activity of rat agrin isoforms depends on the myotubes on which they are tested. On primary rat myotubes and on the mouse C2C12 cell line, all rat agrin isoforms are active in aggregating AChRs (Ferns et al., 1992 . On the other hand, on chick primary myotubes and on variants of the C2C12 cell line that are defective in glycosaminoglycan synthesis, only isoforms containing amino acids at sites A and B are active (Ferns et al., 1992 . Although the ECho of different agrin isoforms were not determined, semiquantitative assays revealed that on the latter cells, rat agrinA4Bs and agrin^4Bt9 were more active than agrinA,8.. To test whether the activity of chick agrin isoforms also depended on the myotubes, we determined the dose dependence of four agrin isoforms on myotubes formed by the C2C12 cell line 400 pM of agrin^4Bs (C95A4BS) and agrinA4~19 (C95A4m9; cFulIA4sI9); and at 64 nM of C95A4B,, maximal response is reached. No cluster-inducing activity is observed for 400 pM of cFulIAoB0 and 64 nM of c95~Bo. Each data point represents mean + SEM of duplicate cultures, where 10 myotube segments were counted in each. AChR dusters without agrin are given (control). Area of AChR clusters induced by c95~, C95A4BI9, cFulIA4B19, and C95A4BII do not differ from each other (p > 0.1). Similarly, no significant difference to the control is observed in cultures treated with cFuI1AoB0 and C95AOBO. (Yaffe and Saxel, 1977; Blau et al., 1983) . Since AChR aggregates on C2C12 myotubes were larger than those on chick myotubes (data not shown), the extent of AChR aggregation was expressed as the percentage area covered by AChR clusters. The EC~0 of c95A4~ and C95^4a19 was ,,o35 pM and that of c95^4B, was ,,ol00-fold lower (data not shown). AS observed on chick myotubes, 400 pM of C95A4m, C95A4~19, and cFull^4B19 induced maximal response, while the same concentration of cFullAoB0 failed to induce AChR clusters (Fig. 5 c) . Consistent with the data on chick myotubes, C95AOB0 did not induce detectable levels of AChR clusters and c95^4B, reached the same maximal response as the other active agrin isoforms (Fig. 5 c) . In summary, induction of AChR aggregates on C2C12 myotubes by recombinant chick agrin closely followed that on chick primary muscle ceils.
A Minimal Fragment with AChR-aggregating Activity
In a subsequent step we investigated which structural domains of agrin confer its AChR-aggregating activity. As a result of our studies on activities of agrin isoforms, we constructed deletion mutants of the most potent agrin isoform agrinA4as and the inactive agrinA0ao. The end point of the deletions was chosen to leave the different domains of agrin intact to promote proper folding of the recombinant protein.
The first deletions started at amino acid 1487 of full-length chick agrin . They contained both sites A and B, two domains homologous to the G domain of laminin ix-chains, and the last EGF-like repeat (c45; Fig. 1) . The second deletions started at amino acid 1722 and contained the B-site and the last G domain (c21; Fig. 1 ). As shown in Fig. 6 , both mutants are secreted efficiently from transiently transfected COS cells. The concentration of c45-and c21-proteins in the conditioned medium was assessed by immunoprecipitating metabolically labeled protein and comparing its [35S] content with that of C95A4B8 that had undergone identical treatment (Fig. 6) . The absolute concentration of C95A4B8 in the conditioned medium was determined by ELISA. In two independent experiments the ratio of c95: c45:c21 was 1:20:30. The increase in concentration for the small proteins c45 and c21 is expected and is an indication that the deletion mutants fold correctly and thus are not degraded intracellularly.
As shown in Fig. 7 , the dose response curve of C45A4~ is slightly shifted compared to that of C95A4BS. In three independent experiments, ECs0 of C45A4B8 was 132 + 17 pM (mean + SEM; N = 3). Hence, C45A4~8 is approximately fourfold less active than C95A4BS. AS observed for C95A0a0, no activity was detected in C45AOBO, even at concentrations of 100 nM. The smallest fragment, c21B8, was still capable of inducing AChR aggregation, with an ECs0 of 13 + 4 nM (mean + SD; N = 2). Its activity depended on the presence of amino acids at the B-site, since c21Bo failed to induce AChR clustering (Fig. 7) . As was observed for agrin isoforms that have different ECs0 values (Figs. 3 and 4) , the maximal number of AChR clusters was the same for both C45A4BS and c21Ba. Thus, an agrin fragment containing the Bs-site and the most COOH-terminal G domain (G3) is sufficient to induce AChR aggregation. Its ECs0 is two orders of magnitude higher, indicating that domain G2 and the last EGF-like repeat contribute to agrin's activity. Exogenous heparin and other polyanions inhibit agrininduced AChR aggregation (Wallace, 1990) . Furthermore, binding of agrin to a-dystroglycan is inhibited by heparin (Bowe et al., 1994; Gee et al., 1994; Campanelli et al., 1994; Sugiyama et al., 1994) . To test whether AChR aggregation induced by c45A4a8 and c21a8 could be inhibited by heparin, chick primary myotubes were incubated for 6 h with approximately four times the amount of recombinant agrin needed to induce half-maximal response. While AChR aggregation induced by c45^4a8 was inhibited by heparin, no inhibition was observed for AChR aggregation induced by c21as (Fig. 8 a) . These results indicate that heparin does not inhibit AChR aggregation per se.
Since 100-fold higher concentrations of c21a8 are needed to induce the same number of AChR clusters as for C45A4U, we tested the heparin-binding properties of c45A4~ and c21,8. Conditioned medium of transfected COS cells was applied to heparin columns and the concentration of recombinant agrin in the flowthrough and the eluate was determined by immunoprecipitation. In agreement with the results on heparin-inhibition of AChR aggregation, c45^4a8 bound to these columns and c21~ was detected in the flowthrough (Fig. 8 b) . We also tested whether this treatment depleted AChR-aggregating activity of the conditioned medium. Indeed, no AChR-aggregating activity was detected in c45A4as-containing medium after heparin column chromatography, while activity in c21as-containing medium was unchanged (data not shown). Thus, c21as has lost the capability of binding heparin, Our results show that it nevertheless retains AChR-aggregating activity, indicating that the binding sites for heparin and for activating a signaltransducing receptor are distinct from each other. The 100-fold higher EC50 of c21~ suggests that the heparin-binding site in agrin may have an important auxiliary function in agrin-induced AChR aggregation.
Discussion
Role of Agrin Isoforms in the Formation of the Neuromuscular Junction
Our results show that agrinA4u and agrinA4a19 are most potent in inducing AChR aggregation. Early in the development of the chick, the most abundant agrin mRNA in cholinergic neurons, such as ciliary ganglia neurons and motor neurons, codes for agrinA4al9 Smith and O'Dowd, 1994; A., M. J. Werle, S. E. Horton, L. S. Honig, and U. J. McMahan, manuscript in preparation). Later, chick motor neurons express high levels of agrinA4aS (Honig, L. S., D. Stone, K. Nikolics, and U. J. McMahan. 1993 . Soc. Neurosci. Abstr. 1272 and its relative abundance increases in chick ciliary ganglia (Thomas et al., 1993) and rat spinal cord . In addition, shows that all C45A4a8 is depleted by heparin columns, while no c21B8 is retained. most agrin mRNA in the electric lobe of Discopyge ommata, which consists of gliai cells and motor neurons innervating the electric organ, encodes agrin^4~ . Thus, it is feasible that cholinergic neurons early in development secrete high amounts of agrin^4Btg, while at later stages and throughout adulthood, they synthesize agrin^4ss. Our results that both isoforms are highly active in inducing AChR aggregation support the hypothesis by McMahan (1990.) that agrin released by motor neurons induces the formation of synapses in the target cell.
As previously shown , agrin^4B, is active in inducing AChR aggregation. With the quantitative assay, we demonstrate here that its ECho is approximately two orders of magnitude higher than that of agrin~Bs or agrin^4B~9. The expression of transcripts encoding agrinA4B~ in tissue containing cholinergic neurons, such as spinal cord and ciliary ganglia, peaks very early in neural development (Thomas et al., 1993; Hoch et al., 1993) , before differentiation to neurons is complete. Precursor cells in the neural tube synthesize mainly agrinm~ and agrinA4BO . Thus, differentiation into neurons may alter the intrinsic splice machinery of the cell such that the 33 bp are inserted at the B-site giving rise to mRNA encoding agrin^4Bu. Subsequent modification of this path later in development may then include the 24-bp exon, leading to the expression of mRNA encoding agrin^413t9 and/or agrin^48~. Thus, alteration of the splicing pattern in differentiating neurons would result in agrin isoforms that are active in inducing postsynaptic structures and agrin^4BH would be the first transient means to achieve this.
In contrast to neurons, muscle cells express high levels of transcripts encoding agrinAoB0 Hoch et ai., 1993; Ma et al., 1994) . In agreement with previous reports , we find that recombinant agrinA0so does not show any activity. From this we conclude that agrin isoforms secreted by muscle cells do not play a primary role in clustering AChRs. This conclusion is strengthened by findings of Reist et al. (1992) that agrin released from motor neurons and not from myotubes induces the formarion of AChR clusters in vitro. Our conclusion would also be in agreement with many other studies in several species showing that the formation of neurotransmitter-receptor clusters in vivo depends on innervation (e.g., Frank and Fischbach, 1979; Dahm and Landmesser, 1991; Liu and Westerfield, 1992; Broadie and Bates, 1993) .
Differential Activities of Chick and Rat Agrin Isoforms
The ability of agrin isoforms to induce AChR clusters has also been tested using rat cDNA clones (Ferns et al., 1992 . With COOH-terminal fragments of agrin^4Bs, agrin^4Bo, and agrinAoB0 that were 78 amino acids longer than chick c95-fragments, agrin^4Bg was ~l,000-fold more potent in inducing AChR clusters on C2 myotubes than agrinA4BO and no activity was detected for agrinA0~o . Thus, AChR-aggregating activity of COOHterminal fragments of rat and chick ^grin isoforms is qualitatively similar although no direct comparison of their dose dependence (ECs0) is possible.
This dependence of AChR-aggregating activity on the composition of agrin at sites A and B is not seen under certain conditions (Ferns et al., 1992 . COS cells that are transfected with full-length rat agrin expressed the protein on their cell surface (CampaneUi et al., 1991) . When tested in this cell-attached form, AChR aggregation on rat primary and on C2 myotubes was induced by all ^grin isoforms. On primary chick myotubes, only agrin^4Bs and agrin^4B19 were highly active, while agrina4B, was moderately active and agrin^4a0 was inactive (Ferns et al., 1992 . In an attempt to find reasons for such behavior of rat agrin, we have determined dose response curves for full-length chick ^grin and have tested some of the chick ^grin isoforms on C2 myotubes. Our findings show that the correlation between AChRaggregating activity and the composition of agrin at sites A and B is influenced by neither the size and the species (chick or ray) of agrin nor the origin of the myotubes (Fig. 5) . Since we used soluble ^grin in all of our assays, we conclude that the presentation of rat agrin on the surface of transfected cells is most likely the reason for the different results. It remains to be seen whether phosphorylarion of the ~ subunit of AChRs observed after the addition of soluble agrin can also be triggered by high local concentrations of weakly active or inactive ^grin isoforms.
Domains of Agrin Involved in AChR Aggregation
To obtain insights into the molecular mechanisms by which ^grin induces AChR aggregation and to assess the role of structural domains of agrin in this process, we determined the ECs0 of deletion mutants of agrin to induce AChR clustering. Agrin fragments lacking the NH2-terminal half, which contains domains that have been proposed to be of potential importance for agrin binding to basal lamina or to certain differentiation factors (discussed in Patthy and Nikolics, 1993) , show the same dose dependence as fulllength agrin^4Bg (Fig. 5 a) . Thus, the 95-kD, COOH-terminal fragment comprises all of the structural domains that contribute to agrin's AChR-aggregating activity. Removing all the domains except those that contain sites A and B resulted in the fragment c45^4Bs with ~4 times higher ECs0 (Fig. 7) . This indicates that either G1 and/or any of the three EGF-like repeats contribute to agrin's AChR-aggregaring activity or that the folding of c45^4B8 is slightly altered. Deletion of G2, containing site A, and the last EGF-like repeat increased ECho by approximately two orders of magnitude (Fig. 7) . Nevertheless, this recombinant fragment was capable of inducing AChR aggregation to the same extent as the other fragments, indicating that the presence of site Bs together with G3 is sufficient for this activity. Our data on heparin binding of c21Bs and inhibition of AChR aggregation by heparin suggest that the higher ECs0 of c21Bs may be due to the loss of the heparin-binding site rather than to the misfolding of the recombinant fragment (see below). We further tested activity of a cyclic peptide with the sequence of Bs and a linear Bs-peptide that was flanked by l 1-amino acid long spacers. Both reagents neither induced nor inhibited AChR aggregation (data not shown), demonstrating that the B insert alone is not sufficient for activity. These results indicate that binding of ^grin to its signal-transducing receptor depends on the secondary structure of the ligand. Consequently, we hypothesize that amino acids of insert B may impose a certain structure on the G3 domain to expose the actual receptor-binding site.
A similar approach to characterize the active site of rat agrin has been taken by Hoch et al. 0994) . Their smallest fragment capable of inducing AChR aggregation was larger than C45A4BS and still contained the third EGF-like repeat. No activity was detected in a fragment similar in size to C45A4B8 that also included G2, the last EGF-like repeat and G3. In contrast to C45A4BS, the rat fragment was poorly secreted from COS cells. According to Hoch et al. (1994) , the amount of the small fragment secreted by COS cells is only ~1/100 of that of their 95-kD fragment. In our experiments, COS cells secrete ,x,20 times more of C45A4BS than C95A4B8. This *2,000-fold difference in secretion between similar constructs in rat and chick raises the possibility that the small agrin fragment in rat may not be folded correctly and hence be degraded, which would explain the failure to detect activity. Similarly, no activity was detected for rat constructs that contained the last EGF-like repeat and the G3 domain. Because Hoch et al. (1994) did not provide data on the concentrations of agrin fragments that were tested in the AChR aggregation assay, it is impossible to assess whether their experimental conditions would have allowed detection of activity of fragments with high ECs0 values.
Possible Mechanisms of Agrin-induced AChR Aggregation
AChR aggregation induced by agrin isolated from the electric organ of Torpedo californica is inhibited by heparin and several other polyanions (Wallace, 1990) . The main fragment of active agrin found in such extracts has a Mr of 95 kD. We show that a 45 kD, COOH-terminal fragment of agrinA4BS still binds to heparin, indicating that domains G2, the fourth EGF-like repeat, and G3 are sufficient for this binding. Since the agrin fragment c21Bs has lost this heparin-binding site, domains G2 and/or the fourth EGF-like repeat are required for heparin-binding. In laminin, the heparin-binding site has been mapped to the elastase fragment E3, which consists of the last two G domains of the terminal globule of the or-chains (Ott et al., 1982; Skubitz et al., 1988 Skubitz et al., , 1991 . In analogy, we suggest that the G2 domain and not the fourth EGF-like repeat of agrin is required to bind heparin.
Heparin bound to agrin could either interfere with sites that are necessary for agrin to interact with its signaltransducing receptor, or prevent binding of agrin to molecules supporting its AChR-aggregating activity. Our finding that the ECso of c21Bs is ~100-fold higher than that of c45A4as suggests the latter possibility to be more likely. Since heparan sulfate also inhibits agrin-and nerve-induced AChR aggregation (Hirano and Kidokoro, 1989; Wallace, 1990) , heparan sulfate proteoglycans that accumulate at both nerve-and agrin-induced AChR aggregates (Anderson and Fambrough, 1983; Wallace, 1989) are possible candidates for proteins that may bind agrin.
Another candidate is the recently identified c~-dystroglycan, a peripheral membrane protein of the dystrophinglycoprotein complex. A 100 kD, COOH-terminal fragment of rat agrin binds to c~-dystroglycan with high affinity and its binding is inhibited by laminin and by low concentrations of heparin Gee et al., 1994; Sugiyama et al., 1994) . Likewise, laminin binding to a-dystroglycan is inhibited by heparin (Ervasti and Campbell, 1993) . The c~-dystroglycan-binding site in laminin has been mapped to fragment E3 and it has been suggested that domains responsible for binding to heparin and c~-dystroglycan are identical (Gee et al., 1993) . We show that in agrin the G2 domain and/or the last EGF-like repeat are required for heparin-binding and we also propose that the binding sites for heparin and ot-dystroglycan overlap.
The following observation supports this hypothesis. Agrin purified from electric organ of Torpedo consists of two major proteolytic fragments (Mr 95 kD and 70 kD) with identical NH2-terminal sequences (Nitkin et al., 1987; Smith et al., 1992) . The 70-kD fragment probably still contains domain G2, but lacks the last EGF-like repeat and G3. Confirming our results that G3 is required for AChR aggregation, the 70 kD fragment is inactive (Nitkin et al., 1987) , but nevertheless it still binds to tx-dystroglycan (Ma et al., 1993) . If c21B8 lacks the binding site to tx-dystroglycan, the 100-fold higher ECs0 of this fragment compared to C45A4B8 suggests that ot-dystroglycan serves as a helper protein to augment agrin's AChR-aggregating activity. Our data on the binding of heparin and its inhibitory effect on AChR aggregation indicate that the so far described binding of agrin to a-dystroglycan is not an absolute requisite for agrin to exert its AChR-aggregating activity. On the other hand, other components of the dystrophin-glycoprotein complex may serve as the signal-transducing receptor. Indeed, the findings that components of the dystrophin-glycoprotein complex are concentrated at agrin-induced AChR clusters in vitro Gee et al., 1994; Sugiyama et al., 1994) as well as at the NMJ (Ohlendieck et al., 1991) suggest that they may contribute to the formation of postsynaptic structures. The possibility that a-dystroglycan may serve as helper protein for agrin's AChR-aggregating activity would fit well with findings for other differentiation factors, such as transforming growth factor-/3 (L6pez- Casillas et al., 1991 Casillas et al., , 1993 Wang et al., 1991) and basic fibroblast growth factor (Rapraeger et al., 1991) where proteoglycans serve as cell surface receptors to present the ligands to their signaling receptors.
